Pricing Log in Create free account

Aurora Cannabis Inc. (ACB) vs Evolus, Inc. (EOLS)

Aurora Cannabis Inc. and Evolus, Inc. are both Drug Manufacturers Specialty & Generic companies. Evolus, Inc. is the larger, with a market value of $448.8M against $341.2M — 1.3× the size. Evolus, Inc. grew revenue faster over the last twelve months: 13.9% against −18.2%. Evolus, Inc. has the higher net margin (−9.56% vs −38.1%) and the lower return on invested capital (−12.6% vs −5.58%). Across the 17 metrics below, Evolus, Inc. leads on 14 and Aurora Cannabis Inc. on 3.

Valuation

Metric ACB EOLS Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.55
P/S 1.53 1.39 2.08
P/B 0.84 n/m 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA n/m n/m 12.22
EV/Sales 1.28 1.98 2.87
Earnings yield (27.12%) (6.85%) (15.94%)
Free cash flow yield (11.26%) (1.94%) 0.00%

Profitability

Metric ACB EOLS Drug Manufacturers Specialty & Generic median
Gross margin 49.74% 66.38% 53.51%
Operating margin (12.13%) (4.79%) 0.00%
Net margin (38.12%) (9.56%) (2.45%)
Free cash flow margin (17.19%) (2.71%) 0.00%
Return on equity (19.85%) 93.47% (0.80%)
Return on assets (15.19%) (12.38%) (1.67%)
Return on invested capital (5.58%) (12.60%) 0.00%

Growth

Metric ACB EOLS Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) (18.18%) 13.87% 5.22%
EPS growth (last fiscal year) (5,266.67%) 1.23% 42.91%
Revenue growth, 5-year CAGR 3.92% 39.36% 7.24%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ACB EOLS Drug Manufacturers Specialty & Generic median
Debt to equity 0.03 (4.15) 0.04
Current ratio 5.36 1.42 2.41
Net debt to EBITDA 5.11 (4.08) 1.01

Dividend

Metric ACB EOLS Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric ACB EOLS Drug Manufacturers Specialty & Generic median
Market cap 341.19m 448.82m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack